Here are eight drug and medical device recalls the FDA recently reported:
1. GE Healthcare recalls 7.5K oxygen monitors
GE Healthcare recalled 7,559 TruSignal sensors — which track arterial oxygen saturation and pulse rate — because the product might reduce energy during defibrillation, carry electrical currents from other sources or inaccurately measure arterial oxygen saturation. The FDA labeled it a Class I recall, and zero injuries or deaths have been reported.
2. 16 injuries lead to Class I recall of Abbott heart device
Abbott recalled 672 cardiac catheters because of an increased risk of air bubbles, which can affect a patient's heartbeat and blood pressure, the FDA said.
3. About 350K Medtronic defibrillators recalled
Medtronic recalled 348,616 implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators because they might fail to deliver energy when high- voltage therapy is needed.
4. Cardiac panel tests recalled for risk of missed heart attacks
Nearly 8,000 cardiac panel blood tests have been recalled after 41 reports of inaccurate test results that pose the risk of missing a heart attack diagnosis, the FDA said.
5. 2 companies recall more than 1K ventilator products
About 1,060 ventilator products between two companies are recalled because of the risk of serious injury or death, according to the FDA.
6. Cipla recalls 6 batches of albuterol
Warren, N.J.-based Cipla USA, a subsidiary of India-based pharmaceutical company Cipla, recalled six batches of albuterol sulfate inhalation aerosol solutions after one complaint of the product leaking.
7. 18 injuries spur recall of 260K catheters with leaking, breaking risk
Teleflex, a global medical supplier with its U.S. operations based in Morrisville, N.C., recalled more than a quarter of a million catheter systems after 83 complaints, 18 injuries and zero deaths were reported.
8. Michigan drugmaker recalls meds in wrong package
Major Pharmaceutical/Rugby Laboratories, based in Livonia, Mich., is recalling one lot of an anti-nausea drug because a distributor found it to be mislabeled as the drugmaker's schizophrenia drug.